Document Detail


Headache in 25 consecutive patients with atrial septal defects before and after percutaneous closure-a prospective case series.
MedLine Citation:
PMID:  21884084     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
(Headache 2011;51:1297-1304) In contrast to patent foramen ovale that is highly prevalent in the general population, atrial septal defect (ASD) is a rare congenital heart defect. The effect of ASD closure on headache and migraine remains a matter of controversy. The objectives of our study were (1) to determine headache prevalence in consecutive patients with ASD scheduled for percutaneous closure for cardiologic indications, using the International Classification of Headache Disorders and (2) to compare headache characteristics before and after closure of ASD. In this observational case series no a priori power analysis was performed. Twenty-five consecutive patients were prospectively included over 27 months. Median duration of follow-up was 12 months [interquartile range 0]. Prevalence of active headache seemed to be higher compared with the general population: any headaches 88% (95% confidence interval 70-96), migraine without aura 28% (14-48), migraine with aura 16% (6-35). After ASD closure, we observed a slightly lower headache frequency (median frequency 1.0 [2.6] vs 0.3 [1.5] headaches per month; P = .067). In patients with ongoing headaches, a significant decrease in headache intensity (median VAS 7 [3] vs 5 [4]; P = .036) was reported. Three patients reporting migraine with aura before the intervention noted no migraine with aura attacks at follow-up, 2 of them reported ongoing tension-type headache, 1 migraine without aura. In summary, this prospective observational study confirms the high prevalence of headache, particularly migraine, in ASD patients and suggests a possible small beneficial effect of ASD closure.
Authors:
Franz Riederer; Helmut Baumgartner; Peter S Sándor; Peter Wessely; Christian Wöber
Related Documents :
25312044 - Malignancy risk in patients with inflammatory eye disease treated with systemic immunos...
25191114 - Radioactive body burden measurements in (131)iodine therapy for differentiated thyroid ...
25487904 - The effects of glenoid wear patterns on patients with osteoarthritis in total shoulder ...
25288174 - Stent-graft placement with early debridement and antibiotic treatment for femoral pseud...
8614194 - Endoscopic treatment of tracheal stenosis using the carbon dioxide laser and the giantu...
25312044 - Malignancy risk in patients with inflammatory eye disease treated with systemic immunos...
Publication Detail:
Type:  Journal Article     Date:  2011-01-26
Journal Detail:
Title:  Headache     Volume:  51     ISSN:  1526-4610     ISO Abbreviation:  Headache     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985091R     Medline TA:  Headache     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1297-304     Citation Subset:  IM    
Copyright Information:
© 2011 American Headache Society.
Affiliation:
From the University Hospital Zurich, Department of Neurology, Zurich, Switzerland (F. Riederer and P.S. Sándor); University Hospital Munster, Adult Congenital and Valvular Heart Disease Center, Department of Cardiology and Angiology, Münster, Germany (H. Baumgartner); RehaClinic, Bad Zurzach, Switzerland (P.S. Sándor); Medical University Vienna, Department of Neurology, Waehringer Guertel, Vienna, Austria (P. Wessely and C. Wöber).
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Which patients with headache do not seek medical attention?
Next Document:  Tolerance to the beneficial effects of prophylactic migraine drugs: a systematic review of causes an...